Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations

Clinical Infectious Diseases

Volumn 43, Issue 4, 2006, Pages 468-473

  Schüttrumpf, Silke ^a   Binder, Lutz ^a   Hagemann, Thorsten ^a   Berkovic, Dinko ^b   Trümper, Lorenz ^a   Bindev, Claudia ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Department of Urology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BACTEREMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTEMIC DISEASE;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; PROTEIN PRECURSORS; ROC CURVE;

EID: 33746651070     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505394     Document Type: Article

References (33)

1. Du Clos TW, Mold C. The role of C-reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis 2001; 14:289-93.
2. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP. C-reactive protein and myocardial infarction. J Clin Epidemiol 2002; 55:445-51.
3. Scherer MA, Neumaier M, von Gumppenberg S. C-reactive protein in patients who had operative fracture treatment. Clin Orthop Relat Res 2001; 393:287-93.
4. Sjowall C, Eriksson P, Aimer S, Skogh T. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmun 2002; 19:155-60.
5. Zebrack JS, Anderson JL. Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practice. Prog Cardiovasc Nurs 2002; 17:174-85.
6. Donadona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-8.
7. Maruna P, Nedelnikova K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res 2000; 49(Suppl 1):S57-61.
8. Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20:1-9.
9. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3:45-50.
10. Assicot M, Gendrel D, Carsin H. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-8.
11. Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation. Cardiovasc Surg 2000; 8:550-4.
12. Kuse ER, Langenfeld I, Jaeger K, Külpmann WR. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 2000; 28:555-9.
13. Engel A, Steinbach G, Kern P, Kern VW. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31:185-9.
14. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000; 111:1093-102.
15. Giamerellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamerellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32:1718-25.
16. Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999; 18:283-5.
17. Sauer M, Tiede K, Volland R, Fuchs D, Zintl F. Procalcitonin and C-reactive protein: comparison of two markers for sepsis syndrome in severely immunocompromised children after bone marrow transplantation. Klin Pädiatr 2000; 212:10-5.
18. Svaldi M, Hirber J, Lanthaler AI, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001; 115:53-7.
19. Giamerellou H, Giamerellos-Bourboulis EJ, Repoussis P, et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 2004; 10:628-33.
20. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23:539-44.
21. Schüttrumpfs, Binder L, Hagemann T, Berkovic D, Trümper L, Binder C. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 2003; 82:98-103.
22. Ablij H, Meinders A. C-reactive protein: history and revival. Eur J Intern Med 2002; 13:412.
23. Johnson HL, Chiou CC, Cho CT. Applications of acute phase reactants in infectious diseases. J Microbiol Immunol Infect 1999; 32:73-82.
24. Arber C, Passweg JR, Fluckiger U, et al. C-reactive protein and fever in neutropenic patients. Scand J Infect Dis 2000; 32:515-20.
25. Kallio R, Surcel HM, Bloigu A, Syrjala H. C-reactive protein and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000; 36:889-94.
26. Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 2002; 4:250-5.
27. Penel N, Fournier C, Degardin M, Kouto H, N'Guyen M. Fever and solid tumor: diagnostic value of procalcitonin and C-reactive protein [in French]. Rev Med Interne 2001; 22:706-14.
28. Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 2000; 28:68-73.
29. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26:1193-200.
30. Penel N, Fournier C, Clisant S, N'Guyen M. Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer 2004; 12:593-8.
31. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39:206-17.
32. Al-Nawas B, Shah PM. Procalcitonin in patients with and without immunosuppression and sepsis. Infection 1996; 24:434-6.
33. de Bont ES, Vellenga E, Swaanenburg J, Kamps W. Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever. Infection 2000; 28:398-400.